Liposomes encapsulating polymeric chitosan based vesicles--a vesicle in vesicle system for drug delivery.

Drug delivery systems comprising vesicles prepared from one amphiphile encapsulating vesicles prepared from a second amphiphile have not been prepared previously due to a tendency of the bilayer components of the different vesicles to mix during preparation. Recently we have developed polymeric vesicles using the new polymer-palmitoyl glycol chitosan and cholesterol in a 2:1 weight ratio. These polymeric vesicles have now been encapsulated within egg phosphatidylcholine (egg PC), cholesterol (2:1 weight ratio) liposomes yielding a vesicle in vesicle system. The vesicle in vesicle system was visualised by freeze fracture electron microscopy. The mixing of the different bilayer components was studied by monitoring the excimer fluorescence of pyrene-labelled polymeric vesicles after their encapsulation within egg PC liposomes or hexadecyl diglycerol ether niosomes. A minimum degree of lipid mixing was observed with the polymeric vesicle-egg PC liposome system when compared to the polymeric vesicle-hexadecyl diglycerol ether niosome system. The polymeric vesicle-egg PC vesicle in vesicle system was shown to retard the release of encapsulated solutes. 28% of 5(6)-carboxyfluorescein (CF) encapsulated in the polymeric vesicle compartment of the vesicle in vesicle system was released after 4 h compared to the release of 62% of encapsulated CF from plain polymeric vesicles within the same time period.

[1]  Alexander T. Florence,et al.  Vesicle (niosome)-in-water-in-oil (v/w/o) emulsions: an in vitro study , 1994 .

[2]  J. Bouwstra,et al.  LARGE DISK-SHAPED STRUCTURES (DISCOMES) IN NONIONIC SURFACTANT VESICLE TO MICELLE TRANSITIONS , 1992 .

[3]  L. Tetley,et al.  Polymeric Chitosan‐based Vesicles for Drug Delivery , 1998, The Journal of pharmacy and pharmacology.

[4]  H. Galla,et al.  Excimer-forming lipids in membrane research. , 1980, Chemistry and physics of lipids.

[5]  M. Cates,et al.  Stuffed onions: Particles in multilamellar vesicles , 1997 .

[6]  A. Florence,et al.  Non-ionic surfactant based organogels incorporating niosomes , 1996 .

[7]  J. Fox.  FDA advisors okay NeXstar's DaunoXome , 1995, Bio/Technology.

[8]  P. Viani,et al.  N-pyrene dodecanoyl sulfatide as membrane probe: a study of glycolipid dynamic behavior in model membranes. , 1988, Chemistry and Physics of Lipids.

[9]  R. New,et al.  Liposomes : a practical approach , 1990 .

[10]  J. Mey.  6 – Colloidal Gold Probes in Immunocytochemistry , 1983 .

[11]  I. Uchegbu,et al.  Erratum: Non-ionic surfactant based vesicles (niosomes) in drug delivery (International Journal of Pharmaceutics 172 (1998) (33-70) PII: S0378517398001690) , 1998 .

[12]  I. Bekersky,et al.  AmBisome (Liposomal Amphotericin B): A Comparative Review , 1998, Journal of clinical pharmacology.

[13]  G Gregoriadis,et al.  Engineering liposomes for drug delivery: progress and problems. , 1995, Trends in biotechnology.

[14]  Ijeoma F. Uchegbu,et al.  Non-ionic surfactant based vesicles (niosomes) in drug delivery , 1998 .

[15]  S. Antimisiaris,et al.  Liposomes as vaccine carriers. Incorporation of soluble and particulate antigens in giant vesicles. , 1993, Journal of immunological methods.

[16]  Phase transitions in aqueous dispersions of the hexadecyl diglycerol ether (C(16)G(2)) non-ionic surfactant, cholesterol and cholesteryl poly-24-oxyethylene ether: Vesicles, tubules, discomes and micelles , 1996 .

[17]  Mathias Winterhalter,et al.  Stealth® liposomes: from theory to product , 1997 .

[18]  A. Schätzlein,et al.  Polyhedral Non‐ionic Surfactant Vesicles , 1997, The Journal of pharmacy and pharmacology.

[19]  H. Pownall,et al.  Pyrene-labeled lipids: versatile probes of membrane dynamics in vitro and in living cells. , 1989, Chemistry and physics of lipids.